Results 121 to 130 of about 9,493 (159)

Thrombotic microangiopathy after kidney transplantation: diagnosis and management strategies. [PDF]

Clin Kidney J
Mirioglu S, Morelle J, Efe O, Hurdogan O, Dirim AB, Kumru G, Lentine KL, Caliskan Y.   +7 more
europepmc   +1 more source

Complement C5 Inhibitor Ameliorates a Case of Dysferlinopathy. [PDF]

Neurol Neuroimmunol Neuroinflamm
Kang S, Wang Q, Lv H, Deng J, Zhang W, Lu X, Yuan Y, Wang Z, Zheng F, Yu M.   +9 more
europepmc   +1 more source

Recurrent Atypical Hemolytic-Uremic Syndrome (aHUS) Associated With CD46 Genetic Mutation: A Report of a Rare Case. [PDF]

Cureus
Biswas N, Adhikari P, Baral N.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Eculizumab☆

Reactions Weekly, 2010
In deep review on eculizumab pharmacology and ...
CATALDI, MAURO, A. Cavaccini
openaire   +3 more sources

Eculizumab

Reactions Weekly, 2023
  +10 more sources

Eculizumab

Drugs, 2012
Kate Mckeage
exaly   +2 more sources

Eculizumab

American Journal of Health-System Pharmacy, 2008
The pharmacology, pharmacokinetics, indications, clinical efficacy, adverse effects, drug interactions, and dosage and administration of eculizumab are reviewed.Eculizumab, a recombinant, humanized, monoclonal, immunoglobulin G antibody produced from murine myeloma cells, is the first agent to be approved for labeling by the Food and Drug ...
openaire   +2 more sources

Eculizumab

Reactions Weekly
Stephanie J. Phelps, Tracy M. Hagemann, Kelley R. Lee   +2 more
  +9 more sources

Eculizumab

Reactions Weekly, 2022
  +4 more sources